冠状动脉旁路移植后患者的心脏生物标志物的动力学,其过程不复杂
Ellen J S Denessen1,2, Brian Swinnen2,3,4, Sacha K Lamers1,2
1Central Diagnostic Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands.
Clinical chemistry
|February 24, 2026
概括
冠状动脉旁路移植 (CABG) 后的生物标志物水平经常超过周围手术性心肌梗塞 (PMI) 的当前值. 这些发现表明,目前PMI的诊断断断可能需要在CABG患者中重新评估.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 心脏外科手术 心脏外科手术
背景情况:
- 冠状动脉旁路移植 (CABG) 后围手术心肌梗塞 (PMI) 的定义和诊断标准没有标准化.
- 目前的生物标志物值,通常基于上限基数的倍数 (URL),可能已经过时,用于评估CABG后的PMI.
- 在这种情况下,高灵敏性心脏热素T (hs-cTnT),高灵敏性心脏热素I (hs-cTnI) 和肌酸激酶MB异型 (CK-MB) 是关键的生物标志物.
研究的目的:
- 为了研究hs-cTnT,hs-cTnI和CK-MB的术后动力学,在接受CABG的患者中.
- 评估目前的PMI诊断切线是否在没有并发症的CABG疗程的患者中被超越.
- 根据手术方法和心脏方案,探索生物标志物水平的变化.
主要方法:
- 预期包括接受隔离式CABG和最少侵入性直接CABG (MIDCAB) 的患者.
- 在重症监护室 (ICU) 抵达时,在手术前和手术后,随后5小时和8小时,以及在术后的第1天和第3天进行序列采血.
- 测量hs-cTnT,hs-cTnI和CK-MB,并根据包装插件或通用样本银行对上限标准化 (URL).
主要成果:
- 在 CABG 患者的高峰hs-cTnT水平为44×URL,hs-cTnI为150×URL,CK-MB为4.5×URL,在ICU到达5小时后.
- 这些高峰生物标志物水平,特别是hs-cTnT和hs-cTnI,明显超过PMI常用的诊断值.
- 至少侵入性直接CABG (MIDCAB) 患者与式CABG相比,生物标志物度较低,在心脏症方案之间观察到显著差异.
结论:
- 在非复杂的CABG病例中,术后生物标志物动力学表明hs-cTnT,hs-cTnI和CK-MB水平经常超过PMI的当前诊断截止值.
- 观察到的生物标志物升高表明需要重新评估并可能更新CABG后PMI的诊断标准.
- 生物标志物水平的变化受到使用的特定高灵敏度热素测定,手术技术 (在上与MIDCAB) 以及心肌的策略的影响.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
979
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
979
01:30Acute Coronary Syndrome III: Diagnostic Studies
325
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
325
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
633
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
507
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
507
01:30Acute Coronary Syndrome I: Introduction
1.2K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.7K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.7K